AU2001248277A1 - Shock heat treatment of polypeptides - Google Patents

Shock heat treatment of polypeptides

Info

Publication number
AU2001248277A1
AU2001248277A1 AU2001248277A AU4827701A AU2001248277A1 AU 2001248277 A1 AU2001248277 A1 AU 2001248277A1 AU 2001248277 A AU2001248277 A AU 2001248277A AU 4827701 A AU4827701 A AU 4827701A AU 2001248277 A1 AU2001248277 A1 AU 2001248277A1
Authority
AU
Australia
Prior art keywords
polypeptides
heat treatment
shock heat
shock
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001248277A
Inventor
Finn Matthiesen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novo Nordisk AS
Original Assignee
Novo Nordisk AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk AS filed Critical Novo Nordisk AS
Publication of AU2001248277A1 publication Critical patent/AU2001248277A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • C07K1/113General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/605Glucagons
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/62Insulins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Endocrinology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AU2001248277A 2000-04-06 2001-04-06 Shock heat treatment of polypeptides Abandoned AU2001248277A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
DKPA200000573 2000-04-06
DKPA200000573 2000-04-06
US19765000P 2000-04-17 2000-04-17
US60197650 2000-04-17
PCT/DK2001/000234 WO2001077141A1 (en) 2000-04-06 2001-04-06 Shock heat treatment of polypeptides

Publications (1)

Publication Number Publication Date
AU2001248277A1 true AU2001248277A1 (en) 2001-10-23

Family

ID=26068808

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001248277A Abandoned AU2001248277A1 (en) 2000-04-06 2001-04-06 Shock heat treatment of polypeptides

Country Status (3)

Country Link
US (1) US6518241B2 (en)
AU (1) AU2001248277A1 (en)
WO (1) WO2001077141A1 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1412384T3 (en) 2001-06-28 2008-04-28 Novo Nordisk As Stable formulation of modified GLP-1
JP2007524592A (en) 2003-06-03 2007-08-30 ノボ・ノルデイスク・エー/エス Stabilized pharmaceutical peptide composition
KR101308912B1 (en) 2003-06-03 2013-09-23 노보 노르디스크 에이/에스 Stabilized pharmaceutical peptide compositions
KR101243648B1 (en) 2003-11-20 2013-03-14 노보 노르디스크 에이/에스 Propylene glycol-containing peptide formulations which are optimal for production and for use in injection devices
EP1789434B1 (en) 2004-08-31 2013-11-20 Novo Nordisk A/S Use of tris(hydroxymethyl) aminomethane for the stabilization of peptides, polypeptides and proteins
EP1817048B1 (en) * 2004-11-12 2014-02-12 Novo Nordisk A/S Stable formulations of insulinoptropic peptides
AU2008292264A1 (en) * 2007-08-24 2009-03-05 Novo Nordisk Health Care Ag Reduction of dimer content in factor VII polypeptide compositions by heat treatment
HRP20240485T1 (en) 2017-08-24 2024-07-05 Novo Nordisk A/S Glp-1 compositions and uses thereof
WO2021123228A1 (en) * 2019-12-18 2021-06-24 Krka, D.D., Novo Mesto Pharmaceutical composition comprising glp-1 analogue
US20230082544A1 (en) 2020-02-18 2023-03-16 Novo Nordisk A/S Pharmaceutical formulations

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4183849A (en) * 1975-01-15 1980-01-15 Nordisk Insulinlaboratorium Therapeutic insulin preparation and a process for the production of a stable insulin preparation with protracted effect
DE3337076A1 (en) * 1983-10-12 1985-05-02 Lentia GmbH Chem. u. pharm. Erzeugnisse - Industriebedarf, 8000 München Process for the production of storage-stable aqueous protein solutions for intravenous administration
FR2583267B1 (en) * 1985-06-17 1990-10-19 Bridel Laiteries PROCESS FOR THE SEPARATION OF WHEY PROTEINS
DE3641115A1 (en) * 1986-12-02 1988-06-16 Lentia Gmbh METHOD FOR PRODUCING AN INTRAVENOUS APPLICABLE AND STABLE IN LIQUID FORM IMMUNOGLOBULINS
CA1337024C (en) * 1988-06-21 1995-09-19 Yoshie Kurihara Method for stabilizing taste-modifier

Also Published As

Publication number Publication date
WO2001077141A1 (en) 2001-10-18
US20020010129A1 (en) 2002-01-24
US6518241B2 (en) 2003-02-11

Similar Documents

Publication Publication Date Title
HK1208446A1 (en) Derivatives of uk-2a uk-2a
EP1463438A4 (en) Endomural therapy
IL156595A0 (en) Therapeutic heterocyclic compounds
GB2373565B (en) Detonation transfer subassembly and method for use of the same
AU2001248277A1 (en) Shock heat treatment of polypeptides
AU2207301A (en) Use of heat shock proteins
HUP0500734A3 (en) Use of 2-alkoxyphenyl-substituted imidazotriazinones
AU2002335667A1 (en) Modified reoviral therapy
GB0101933D0 (en) Therapy
EP1218407A4 (en) Uses of kappa-conotoxin pviia
IL161178A0 (en) MODIFICATIONS OF SOLID 3-sn-PHOSPHOGLYCERIDES
GB0124710D0 (en) Therapeutic composition
GB2381455B (en) Treatment of burns
AU2001292897A1 (en) Novel therapy
AU2001253560A1 (en) Methods of treatment
AU2002351728A1 (en) Heat treatement of wood
AU2002217895A1 (en) Inducing expression of heat shock proteins
AU2001285814A1 (en) Use of the heat shock protein gp96
GB2384548B (en) Hand grenade
AU2002325139A1 (en) Unit-built heating body
AU2633P (en) Darzing Sunset Zingiber spectabile
PL345075A1 (en) Grenade
AU2002343911A1 (en) Hand grenade
GB0125160D0 (en) Infrared spectrascopy of large amonications
TW461254U (en) Structure of heater